Page last updated: 2024-08-23
paclitaxel and bgp 15
paclitaxel has been researched along with bgp 15 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bárdos, G; Bernáth, S; Farkas, B; Jaszlits, L; Literáti-Nagy, B; Literáti-Nagy, P; Móricz, K; Rabloczky, G; Rácz, I; Sümegi, B; Tory, K | 1 |
Other Studies
1 other study(ies) available for paclitaxel and bgp 15
| Article | Year |
|---|---|
BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Body Weight; Cell Survival; Cisplatin; Electrophysiology; Male; Motor Neurons; Neural Conduction; Neurons, Afferent; Oximes; Paclitaxel; Peripheral Nervous System Diseases; Piperidines; Rats | 2003 |